Trial reportAtencion primaria2012
[Suitability of the use of benzodiazepines prescribed by the pharmacist in the elderly. A doctor-pharmacist collaboration study].
Trial report in Atencion primaria, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 22 citations in OpenAlex.
- Risk Characterization in Patients Using Benzodiazepines While Providing Pharmaceutical Care Dispensing Service.Pharmacy (Basel, Switzerland) · 2024Article
- [Pharmaceutical Interventions in Benzodiazepine users during the COVID-19 Pandemic].Farmaceuticos comunitarios · 2024Observational
- Quality of Life Assessment in Patients Using Benzodiazepines during the COVID-19 Pandemic in a Community Pharmacy Using EuroQol 5D-3L.Pharmacy (Basel, Switzerland) · 2023Article
- Prevalence of Gabapentinoids and Central Nervous System Depressant Drugs, and Their Association with Risk Factors for Respiratory Depression in Primary Care Patients.Clinical drug investigation · 2022Article
- [Health-related quality of life in patients consuming benzodiazepine].Atencion primaria · 2021Article
- Review
- Role and impact of pharmacists in Spain: a scoping review.International journal of clinical pharmacy · 2018Article
- Decision Tree for Early Detection of Cognitive Impairment by Community Pharmacists.Frontiers in pharmacology · 2018Article
- Drug-drug interactions and adverse drug reactions in polypharmacy among older adults: an integrative review.Revista latino-americana de enfermagem · 2016Review
- Recent Literature on Medication Errors and Adverse Drug Events in Older Adults.Journal of the American Geriatrics Society · 2016Review
- Why aren't pharmacists included as prescribers in the Controlled Drugs and Substances Act?Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimsTo improve the use of benzodiazepines (BZD) in the elderly by a pharmacist-physician collaboration, and to insure that BZD are effective, safe, and used as long as necessary.
designA single blind controlled study was conducted on 11 pharmacies in the Community of Valencia.
settingEleven pharmacies in the Community of Valencia.
participantsPatients older than 65 years treated with BZD attending the participating pharmacies.
interventionsInterviews and pharmaceutical care for a year. MAIN MEASUREMENT: detection of duplications, adverse drug reactions, drug interactions and measuring the effectiveness of the treatment.
resultsWe studied 314 patients, randomised to control or intervention and who used 346 BZD. The majority (67%) of patients used BZD for more than 1 year. Only 5% patients with anxiety knew the duration of treatment should be one month. Long-acting BZD were used by 20% of the patients, 76% used medium-acting (39% lorazepam and 37% other BZD) and 4% short-acting BZD. A total of 132 drug interactions were detected and 278 adverse drug reactions: 32% memory loss, 21% drowsiness, 12% lack of coordination, 8.3% dizziness and confusion, 8,3% disorientation and 10% others. A total of 426 pharmacist interventions were performed, 30 accepted by the doctor and 78 were resolved at the end of the year of study. Eleven per cent of cases were considered satisfactory in the control group and 30% in the intervention group.
conclusionThe use of benzodiazepines in the Community of Valencia exceeds the recommendations of the Spanish Medicines Agency.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.